Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-11-17

Clinical Trial Update: A Phase Ⅱ/Ⅲ Study of HRS-2129 for Postsurgical Pain Management in Abdominal Surgery [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial evaluating HRS-2129 for postoperative analgesia after abdominal surgery is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HRS-2129

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Postoperative Analgesia | Phase 2, Phase 3 | Status: RECRUITING